✦ LIBER ✦

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. IV. Discovery of 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-{2-methoxy-1( R )-4-(trifluoromethyl)phenyl}ethyl-3( S )-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a Potent, Highly Selective, and Orally Bioavailable CCR5 Antagonist

✍ Scribed by Tagat, Jayaram R.; McCombie, Stuart W.; Nazareno, Dennis; Labroli, Marc A.; Xiao, Yushi; Steensma, Ruo W.; Strizki, Julie M.; Baroudy, Bahige M.; Cox, Kathleen; Lachowicz, Jean; Varty, Geoffrey; Watkins, Robert

Book ID: 120935074
Publisher: American Chemical Society
Year: 2004
Tongue: English
Weight: 78 KB
Volume: 47
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm0304515

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Piperazine-Based CCR5 Antagonists as HIV

Piperazine-Based CCR5 Antagonists as HIV-1 Inhibitors. II. Discovery of 1-[(2,4-Dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3( S )-methyl-4-[1( S )-[4-(trifluoro- methyl)phenyl]ethyl]-1-piperazinyl]- piperidine N 1-Oxide (Sch-350634), an Orally Bioavailable, Potent CCR5 Antagonist

✍ Tagat, Jayaram R.; Steensma, Ruo W.; McCombie, Stuart W.; Nazareno, Dennis V.; L 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 68 KB